Morelos-Hernández EY, Rojas-Díaz CU

Language: Spanish
References: 6
Page: 303-305
PDF size: 172.22 Kb.

Text Extraction

No abstract.

REFERENCES

1. Fontanilles J, Valls A, Franch J, Barrot J,Mundet X, La Torre A, Moreno A, Sagarra R,et al. Effect of lipids on diabetic retinopathyin a large cohort of diabetic patients after 10years of follow-up. J Clin Med. 2023;12:6674.

2. Niño MC, Martínez DE. Morphological segmentationand level classification for diabeticand hypertensive retinopathy through ophthalmicimages and convolutional networks. IngCompetit. 2024;26(1):e-20513181.

3. Shen FC, Chu CH, Chen JF, Kuo CS, HsuCY, Lin CH, et al. Optimizing lipid controlin Taiwanese diabetic patients: a collaborativeconsensus by the Diabetes Association of theRepublic of China (Taiwan) and the TaiwaneseAssociation of Diabetes Educators. J DiabetesInvestig. 2024;15(8):1151–60.

4. Xiao Y, Yu B, Chao C, Wang S, Hu D,Wu C, et al. Chinese expert consensus onblood lipid management in patients withdiabetes (2024 edition). J Transl Int Med.2024;12(4):325–43.

5. Liu S, Zhu Z, Yu K, Zhang W, Pu J, Lv Y, etal. The association between composite dietaryantioxidant index and diabetic retinopathy intype 2 diabetic patients: evidence from theNHANES. Front Nutr. 2024;11:1399763.

6. Zhao M, Zhang D, Zhang Q, Lin Y, CaoH. Association between composite dietaryantioxidant index and hyperlipidemia: a crosssectionalstudy from NHANES (2005–2020).Sci Rep. 2024;14(1):1–9.